Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
4.790
+0.240 (5.27%)
At close: Apr 21, 2025, 4:00 PM
4.860
+0.070 (1.46%)
Pre-market: Apr 22, 2025, 9:01 AM EDT

Altimmune Market Cap

Altimmune has a market cap or net worth of $368.90 million as of April 22, 2025. Its market cap has decreased by -41.54% in one year.

Market Cap
368.90M
Enterprise Value
238.69M
1-Year Change
-41.54%
Ranking
Category
Stock Price
$4.79

Market Cap Chart

Since October 6, 2005, Altimmune's market cap has increased from $81.50M to $368.90M, an increase of 352.63%. That is a compound annual growth rate of 8.03%.

History

DateMarket Cap% Change
Apr 21, 2025368.90M-28.06%
Dec 31, 2024512.80M-15.16%
Dec 29, 2023604.40M-25.26%
Dec 30, 2022808.70M122.17%
Dec 31, 2021364.00M-2.41%
Dec 31, 2020373.00M1,186.21%
Dec 31, 201929.00M61.11%
Dec 31, 201818.00M-42.12%
Dec 29, 201731.10M-85.66%
Dec 30, 2016216.90M77.06%
Dec 31, 2015122.50M6.80%
Dec 31, 2014114.70M17.88%
Dec 31, 201397.30M79.52%
Dec 31, 201254.20M-11.58%
Dec 30, 201161.30M-64.57%
Dec 31, 2010173.00M210.59%
Dec 31, 200955.70M-6.39%
Dec 31, 200859.50M-31.77%
Dec 31, 200787.20M1.04%
Dec 29, 200686.30M4.10%
Dec 30, 200582.90M1.72%
View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 754.27B
UnitedHealth Group 415.38B
Johnson & Johnson 379.48B
AbbVie 306.02B
Novo Nordisk 284.50B
Abbott Laboratories 227.16B
Novartis AG 209.93B
AstraZeneca 208.11B
Market Cap Rankings